The distribution of these markers during tumor progression (Figure 2B) was as follows: PIMO was the main marker during the early stage (day 3), while HIF-1α and CAIX expression became evident as tumor growth progressed (days 5 to 10). The gene discussed is HIF1A; the disease is neoplasm.